Assert-IQ Insertable Cardiac Monitor— 510(k) K230286

Name: FDA 510(k) clearance K230286
Creator: U.S. Food and Drug Administration
Published: 2023-05-17

Substantially Equivalent

ABBOTT MEDICAL

FDA 510(k) clearance K230286 for Assert-IQ Insertable Cardiac Monitor, Substantially Equivalent on 2023-05-17. Applicant: ABBOTT MEDICAL. Device class: 2.

Clearance details

Applicant: ABBOTT MEDICAL
Product code: Code MXC
Device class: Class 2
Regulation: 21 CFR 870.2800
Advisory panel: Cardiovascular
Date received: 2023-02-02
Decision date: 2023-05-17
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Sylmar, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code MXC

view all

K212206 — Jot Dx Insertable Cardiac Monitor2021-08-13
K202876 — Confirm Rx Insertable Cardiac Monitor2020-12-01
K202888 — Confirm Rx Insertable Cardiac Monitor2020-11-23
K193310 — myMerlin Mobile Application (Android), myMerlin Mobile Application (iOS)2020-03-17
K192593 — Confirm Rx Insertable Cardiac Monitor2019-10-18

More clearances from ABBOTT MEDICAL

view all

K262006 — EnSite X EP System2026-07-15
K261631 — Amplatzer TorqVue Exchange System2026-06-17
K253459 — OPTIS Mobile Next Imaging System (1014932) +2 more2026-04-24
K260212 — EnSite X EP System2026-04-20
K253907 — Disposable Radiofrequency Cannula2026-04-16

Adverse events under product code MXC

product code MXC

Death: 4
Injury: 758
Malfunction: 5,066
Total: 5,828

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.